Entera Bio (ENTX) Current Leases (2020 - 2026)
Entera Bio (ENTX) recorded quarterly Current Leases of $185000.0 in Q1 2026, down 19.57% on a QoQ basis from $230000.0 in Q4 2025, and up 9.47% year-over-year from $169000.0 in Q1 2025.
Entera Bio (ENTX) Current Leases (2020 - 2026) Analysis & Trends
Entera Bio has disclosed Current Leases across 7 years of filings, most recently posting $185000.0 for Q1 2026.
- Quarterly Current Leases rose 9.47% year-over-year to $185000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185000.0 (up 9.47% YoY) and the FY2025 annual result came in at $230000.0, up 35.29% from the prior year.
- Current Leases retreated to $185000.0 in Q1 2026, from $230000.0 in the prior quarter.
- Over five years, Current Leases peaked at $230000.0 in Q4 2025 and troughed at $48000.0 in Q1 2023.
- A 5-year average of $151470.6 and a median of $155000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases plunged 66.2% — and 2024, when it jumped 218.75%.
- Tracing ENTX's Current Leases over 5 years: stood at $91000.0 in 2022, then soared by 47.25% to $134000.0 in 2023, then increased by 26.87% to $170000.0 in 2024, then surged by 35.29% to $230000.0 in 2025, then dropped by 19.57% to $185000.0 in 2026.
- Business Quant data shows ENTX's Current Leases at $185000.0 in Q1 2026, $230000.0 in Q4 2025, and $170000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | 185,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 185,000.00 |
| Dec 31, 2025 | 230,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 170,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 155,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 134,000.00 |
| Sep 30, 2023 | 131,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Mar 31, 2023 | 48,000.00 |
| Dec 31, 2022 | 91,000.00 |
| Sep 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 172,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | 179,000.00 |
| Dec 31, 2020 | 189,000.00 |